UA106971C2 - Derivative of imidazopyrazine and pharmaceutical compositions on its basis - Google Patents

Derivative of imidazopyrazine and pharmaceutical compositions on its basis

Info

Publication number
UA106971C2
UA106971C2 UAA201107999A UAA201107999A UA106971C2 UA 106971 C2 UA106971 C2 UA 106971C2 UA A201107999 A UAA201107999 A UA A201107999A UA A201107999 A UAA201107999 A UA A201107999A UA 106971 C2 UA106971 C2 UA 106971C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutical compositions
imidazopyrazine
derivative
basis
methods
Prior art date
Application number
UAA201107999A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Скотт А. Мітчелл
Кевін С. Керрі
Пітер А. Бломгрен
Джеффрі Е. Кропф
Сеунг Х. Лі
Цзянюнь Ксу
Дуглас Г. Стаффорд
Джеймс П. Гардінг
Антоніо Дж. мол. Барбоса
Жонгдонг Жао
Дейвід М. Армістід
Original Assignee
Гіліад Коннектікут, Інк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гіліад Коннектікут, Інк. filed Critical Гіліад Коннектікут, Інк.
Priority claimed from PCT/US2009/006445 external-priority patent/WO2010068257A1/en
Publication of UA106971C2 publication Critical patent/UA106971C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Certain imidazopyrazines and pharmaceutical compositions thereof are provided herein. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of Syk activity, which comprises administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are provided. Also provided are methods for determining the presence or absence of Syk kinase in a sample.
UAA201107999A 2008-12-08 2009-12-07 Derivative of imidazopyrazine and pharmaceutical compositions on its basis UA106971C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12058708P 2008-12-08 2008-12-08
PCT/US2009/006445 WO2010068257A1 (en) 2008-12-08 2009-12-07 Imidazopyrazine syk inhibitors

Publications (1)

Publication Number Publication Date
UA106971C2 true UA106971C2 (en) 2014-11-10

Family

ID=56291501

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201107999A UA106971C2 (en) 2008-12-08 2009-12-07 Derivative of imidazopyrazine and pharmaceutical compositions on its basis

Country Status (1)

Country Link
UA (1) UA106971C2 (en)

Similar Documents

Publication Publication Date Title
MX2011006091A (en) Imidazopyrazine syk inhibitors.
EP3552607A3 (en) Imidazopyrazine syk inhibitors
MX2012010418A (en) Imidazopyridines syk inhibitors.
EA200802167A1 (en) DRUGS AND APPLICATIONS
MY166890A (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
PH12014500472A1 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
WO2007053661A3 (en) Uses of anti-cd40 antibodies
PH12012501480A1 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
UA101167C2 (en) Pharmaceutical composition useful for the treatment of ocular disease
AU2012286851A8 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
MX2009012625A (en) Methods of treating, diagnosing and detecting fgf21-associated disorders.
BRPI0818437B8 (en) antibody or antibody functional fragment, pharmaceutical composition, use of at least one of the antibodies or antibody functional fragments, and hybridoma
WO2007103373A3 (en) Compositions and methods for the treatment of immunoinflammatory disorders
NZ584642A (en) Factor involved in latent infection with herpesvirus, and use thereof
TW200716172A (en) Pharmaceutical compositions for treating lower motor neuron diseases
WO2010068935A3 (en) Small molecule immunomodulators for alzheimer's disease
WO2006138372A3 (en) Methods and reagents for the treatment of inflammatory disorders
UA106971C2 (en) Derivative of imidazopyrazine and pharmaceutical compositions on its basis
WO2007047205A8 (en) Enzyme inhibitors of pai-1
SG162829A1 (en) Humanised antibodies specific for nogo-a and pharmaceutical uses thereof
WO2011112859A3 (en) Methods relating to olanzapine pharmacogenetics
Gόmez et al. AB0747 Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 9 patients
MY156251A (en) Glucuronidated acetaminophen as a marker of hepatic disorders
Kay et al. Cyclophosphamide remains an important component of treatment in CLL patients receiving pentostatin and rituximab based chemoimmunotherapy
Kucan et al. Agents acting on renin-angiotensin system: the impact of generics and price trends in Croatia